Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age related macular degeneration
|
349 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.860 | 1.000 | 2 | 2010 | 2018 | |||||
Metabolic Syndrome X
|
124 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.830 | 1.000 | 2 | 2010 | 2018 | |||||
High density lipoprotein measurement
|
1440 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.800 | 1.000 | 22 | 2008 | 2019 | |||||
Serum total cholesterol measurement
|
1243 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.800 | 1.000 | 8 | 2010 | 2019 | |||||
Triglycerides measurement
|
1418 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.800 | 1.000 | 6 | 2009 | 2018 | |||||
Low density lipoprotein cholesterol measurement
|
1142 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.800 | 1.000 | 5 | 2010 | 2019 | |||||
Lipids measurement
|
53 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.800 | 1.000 | 1 | 2012 | 2012 | |||||
Serum HDL cholesterol measurement
|
679 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.700 | 1.000 | 8 | 2008 | 2013 | |||||
Serum LDL cholesterol measurement
|
555 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.700 | 1.000 | 3 | 2010 | 2013 | |||||
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
526 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||
AIDS, PROGRESSION TO
|
526 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||
Coronary heart disease
|
469 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
Exudative age-related macular degeneration
|
69 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||
exudative macular degeneration
|
69 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||
HIV-1, RESISTANCE TO
|
526 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
527 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||
Pseudocholinesterase Measurement
|
568 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.700 | 1.000 | 1 | 2011 | 2011 |